These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37145463)

  • 1. Management Patterns for Benign Prostatic Hyperplasia: Impact of a Patient Decision Aid.
    Sadik JE; Lambrechts S; Kwan L; Liu H; Shirk J; Weiser CE; Saigal C
    Urol Pract; 2021 Jul; 8(4):523-528. PubMed ID: 37145463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of a web-based treatment decision aid for men with lower urinary tract symptoms due to benign prostatic hyperplasia.
    van der Wijden FC; de Angst IB; Lamers RED; Cuypers M; de Vries M; van Melick HHE; de Beij JS; Oerlemans DJAJ; van de Beek K; Kil PJM
    BJU Int; 2019 Jul; 124(1):124-133. PubMed ID: 30589205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in initial benign prostatic hyperplasia management between primary care physicians and urologists.
    Hollingsworth JM; Hollenbeck BK; Daignault S; Kim SP; Wei JT
    J Urol; 2009 Nov; 182(5):2410-4. PubMed ID: 19765742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benign prostatic hyperplasia evaluation and management by urologists and primary care physicians: practice patterns from the observational BPH registry.
    Wei JT; Miner MM; Steers WD; Rosen RC; Seftel AD; Pasta DJ; Carman WJ; Roehrborn CG;
    J Urol; 2011 Sep; 186(3):971-6. PubMed ID: 21791352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment choice for benign prostatic hyperplasia: a matter of urologist preference?
    Stoevelaar HJ; Van de Beek C; Casparie AF; McDonnell J; Nijs HG
    J Urol; 1999 Jan; 161(1):133-8. PubMed ID: 10037385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choice between prostatectomy and radiotherapy when men are eligible for both: a randomized controlled trial of usual care vs decision aid.
    van Tol-Geerdink JJ; Willem Leer J; Weijerman PC; van Oort IM; Vergunst H; van Lin EN; Alfred Witjes J; Stalmeier PF
    BJU Int; 2013 Apr; 111(4):564-73. PubMed ID: 22882966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decision aids for people facing health treatment or screening decisions.
    Stacey D; Légaré F; Col NF; Bennett CL; Barry MJ; Eden KB; Holmes-Rovner M; Llewellyn-Thomas H; Lyddiatt A; Thomson R; Trevena L; Wu JH
    Cochrane Database Syst Rev; 2014 Jan; (1):CD001431. PubMed ID: 24470076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Factors determining treatment strategies for patients with benign prostatic hyperplasia. The DUO study].
    Fourcade RO; Picot MC; Gaudin AF; Texier N; Slama A
    Presse Med; 2007 May; 36(5 Pt 1):755-63. PubMed ID: 17329070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment preference patterns during a videotape decision aid for benign prostatic hyperplasia (BPH).
    Wills CE; Holmes-Rovner M; Rovner D; Lillie J; Kelly-Blake K; Bonham V; Williams G
    Patient Educ Couns; 2006 Apr; 61(1):16-22. PubMed ID: 16533674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world therapeutic management and evolution of patients with benign prostatic hyperplasia in primary care and urology in Spain.
    Miñana B; Molero JM; Agra Rolán A; Martínez-Fornes MT; Cuervo Pinto R; Lorite Mingot D; Carreño Á; Palacios-Moreno JM
    Int J Clin Pract; 2021 Aug; 75(8):e14250. PubMed ID: 33884719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decision Aid for Trapeziometacarpal Arthritis: A Randomized Controlled Trial.
    Wilkens SC; Ring D; Teunis T; Lee SP; Chen NC
    J Hand Surg Am; 2019 Mar; 44(3):247.e1-247.e9. PubMed ID: 30031600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia, 2004 to 2013: the Urologic Diseases in America Project.
    Welliver C; Feinstein L; Ward JB; Fwu CW; Kirkali Z; Bavendam T; Matlaga BR; McVary KT;
    J Urol; 2020 Jan; 203(1):171-178. PubMed ID: 31430232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient reactions to a program designed to facilitate patient participation in treatment decisions for benign prostatic hyperplasia.
    Barry MJ; Fowler FJ; Mulley AG; Henderson JV; Wennberg JE
    Med Care; 1995 Aug; 33(8):771-82. PubMed ID: 7543639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a decision aid for the treatment of benign prostatic hyperplasia: A four stage method using a Delphi consensus study.
    Lamers RED; Cuypers M; Garvelink MM; de Vries M; Bosch JLHR; Kil PJM
    Patient Educ Couns; 2016 Jul; 99(7):1249-1256. PubMed ID: 26899631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the impact of CTMH guidelines on the management of benign prostatic hyperplasia].
    Lebdai S; Rahmène Azzouzi A; Delongchamps NB; Benchikh A; Campeggi A; Cornu JN; Dumonceau O; Faix A; Fourmarier M; Haillot O; Lukacs B; Mathieu R; Misrai V; Robert G; de La Taille A; Descazeaud A
    Prog Urol; 2015 Jan; 25(1):47-53. PubMed ID: 25453357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of patients with benign prostatic hyperplasia by urologists: the DUO study].
    Fourcade RO; Picot MC; Gaudin AF; Texier N; Slama A
    Ann Urol (Paris); 2006 Nov; 40 Suppl 3():S58-63. PubMed ID: 17366856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug treatment patterns for the management of men with lower urinary tract symptoms associated with benign prostatic hyperplasia who have both storage and voiding symptoms: a study using the health improvement network UK primary care data.
    Hakimi Z; Johnson M; Nazir J; Blak B; Odeyemi IA
    Curr Med Res Opin; 2015 Jan; 31(1):43-50. PubMed ID: 25333647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decision aids for people facing health treatment or screening decisions.
    Stacey D; Bennett CL; Barry MJ; Col NF; Eden KB; Holmes-Rovner M; Llewellyn-Thomas H; Lyddiatt A; Légaré F; Thomson R
    Cochrane Database Syst Rev; 2011 Oct; (10):CD001431. PubMed ID: 21975733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decision aids for benign prostatic hyperplasia and prostate cancer.
    Arterburn D; Wellman R; Westbrook EO; Ross TR; McCulloch D; Handley M; Lowe M; Cable C; Zeliadt SB; Hoffman RM
    Am J Manag Care; 2015 Feb; 21(2):e130-40. PubMed ID: 25880488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical treatment of benign prostatic hyperplasia: physician and patient preferences and satisfaction.
    Emberton M
    Int J Clin Pract; 2010 Sep; 64(10):1425-35. PubMed ID: 20579137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.